Effectiveness, persistence of use, and safety of orlistat and liraglutide in a group of patients with obesity.

Luis Fernando Valladales-RestrepoNicolás Sánchez-RamírezAndrés Felipe Usma-ValenciaAndrés Gaviria-Mendoza Manuel Enrique Machado-Duque Jorge Enrique Machado-Alba

Published in: Expert opinion on pharmacotherapy (2023)

Orlistat and liraglutide users presented weight loss at 12-16 weeks. However, this effect was greater and sustained with liraglutide, especially when combined with physical activity.

Keyphrases

weight loss
physical activity
bariatric surgery
roux en y gastric bypass
randomized controlled trial
insulin resistance
metabolic syndrome
gastric bypass
systematic review
type diabetes
weight gain
gestational age
adipose tissue
obese patients